ANALYTICAL AND
FORENSIC
TOXICOLOGY
MA. OLIVA DIANA D. CASTRO
MS CHEM ED
ANALYTICAL TOXICOLOGY
 APPLICATION OF TOOLS OF
ANALYTICAL CHEMISTRY TO THE
QUALITATIVE AND QUANTITATIVE
ESTIMATIO OF CHEMICALS THAT MAY
EXERT ADVERSE EFFECTS ON LIVING
ORGANISMS
FORENSIC TOXICOLOGY
 USE OF TOXICOLOGY FOR THE
PURPOSES OF LAW
 IDENTIFY ANY CHEMICAL THAT MAY
SERVE AS A CAUSATIVE AGENT IN
INFLICTING DEATH OR INJURY IN
HUMANS OR IN CAUSATING DAMAGE
TO PROPERTY
TOXICOLOGICAL
INVESTIGATION OF A POISON
DEATH INVOLVES:
 OBTAINING THE CASE HISTORY IN AS
MUCH DETAIL AS POSSIBLE AND
GATHERING SUITABLE SPECIMENS
 CONDUCTING SUITABLE
TOXICOLOGICAL ANALYSES BASED ON
THE AVAILABLE SPECIMENS AND;
 INTERPRETATION OF THE ANYLICAL
FINDINGS
SYSTEMATIC/STANDARD
APPROACH
(Chapuis-1873)
 GASES-MEASURED BY GAS
CHROMATOGRAPHY (GC)
 VOLATILE SUBSTANCE- VAPORIZE AT
AMBIANT TEMPERATURE GC IS SIMPLEST
APPROACH FOR SEPARATION AND
QUANTIFICATION
 CORROSIVE AGENTS- MINERAL ACIDS AND
BASES, CONSIST OF IONS THAT ARE
TISSUE CONSTITUENTS, CHEMICAL
TECNIQUES IS APPLIED
 ME TALS-ENCOUNTERED FREQUENTLY AS
OCCUPATIONAL AND ENVIRONMENTAL
HAZARDS, SEPARATION INVOLVES
DESCTRUCTION OF THE ORGANIC MATRIX BY
CHEMICAL AND THERMAL OXIDATION.
 ANIONS AND NONMETALS- ANALYTICAL
CHALENGE SINCE RARELY ENCOUNTERED.
 NONVOLATILE ORGANIC SUBSTANCES-
LARGEST GROUP (PESTCIDES, NATURAL
PRODUCTS, POLLUTANTS, AND INDUSTRIAL
COMPOUNDS.
SEPARATION OF POISONS
FROM TISSUES
ROLE IN GENERAL
AND FORENSIC
TOXICOLOGY
 CHEMICAL UNDER STUDY MUST BE PURE
OR NATURE OF ANY CONTAMINANT WELL-
CHARACTERIZED TO ENABLE
INTERPRETATION OF THE EXPERIMENTAL
RESULTS WITH VALIDITY.
 CHEMICALS MAY DEGRADE WHEN IN
CONTACT WITH AIR, BY EXPOSURE TO
ULTRAVIOLET OR OTHER RADIATION, BY
INTERACTION WITH CONSTITUENTS OF
DOSING SOLUTINS AND OTHER MEANS.
 DEVELOPIN ANAYTICAL PROCEDURE BY
WHICH THESE CHANGES CAN BE
RECOGNIZED AND CORRECTED IS
ESSNTIAL IN ACHIEVING CONSISTENT
AND RELIABLE RESULTS OVER THE
COURSE OF STUDY.
 ANALYTICAL METHODS ARE NECESSARY
TO DETERMINE THE BIOAVAILABILITY
OF COMPOUND THAT IS UNDER STUDY.
ROLE IN FORENSIC
TOXICOLOGY
 INCLUDES QUALITATIVE AND
QUANTITAVE ANALYSIS OF DRUGS OR
POISONS IN BIOLOGICAL SPECIMENS
COLLECTED AT AUTOPSY AND
ANALYTICAL FINDINGS WITH RESPECT
TO THE PHYSIOLOGICAL AND
BEHAVIORAL EFFECTS OF THE
DETECTED CHEMICALS ON THE
DECEASED AT THE TIME OR INJURY
AND/OR DEATH.
 RESULTS OF POSTMODERN TOXICOLOGICAL
TESTING PROVIDE VALAUABLE
EPIDEMIOLOGIC AND STATISTIC DATA.
 CHEMICAL IDENTITY AND TOXICITY OF
NOVEL ANALOGS OF PSYCHOACTIVE AGENTS
THAT ARE SUBJECT TO ABUSE, INCLUDING
“DESIGNER DRUGS” SUCH AS “CHINA WHITE”
(METHYLFENTANYL), “ECSTASY”
(METHYLDIOXYMETHAMPHETAMINE), AND
GHB (GAMMA-HYDROXYBUTYRIC ACID).
TOXICOLOGICAL
INVESTIGATION OF A POISON
DEATH
three steps:
 (1) obtaining the case history and
suitable specimens,
 (2) the toxicologic analyses, and
 (3) the interpretation of the analytic
 findings
CASE HISTORY OF SPECIMENS
 Today, thousands of compounds are
readily available that are lethal if
ingested, injected, or inhaled.
 Usually, a limited amount of specimen
is available on which to perform
analyses; therefore it is imperative that,
before the analyses are initiated, as
much information as possible
concerning the facts of the case be
collected
TOXICOLOGICAL ANALYSIS
 Before the analysis begins, several
factors must be considered, the amount
of specimen available, the nature of the
poison sought, and the possible
biotransformation of the poison.
 In cases involving oral administration of
the poison, the gastrointestinal (GI)
contents are analyzed first because
large amounts of residual unabsorbed
poison may be present.
FORENSIC URINE DRUG
TESTING
 URINE ANALYSIS FOR CONTROLLED OR
ILLICIT DRUGS
 ROUTINELY IN MILITARY SERVICES,
REGULATED TRANSPORTATION AND
NUCLEAR INDUSTRIES, MANY FEDERAL
AND STATE AGENCIES, PUBLIC
UTILITIES, FEDERAL AND STATE
CRIMINAL JUSTICE SYSTEMS, AND
NUMEROUS PRIVATE BUSINESS AND
INDUSTRIES.
 SIGNIFICANT AND ETHICAL
RAMIFICATIONS
 POSITIVE RSULT- MAY NOT BE
EMPLOYED, DISMISSED FROM JOB, BE
COURT-MARTIALED, SUFFER DAMAGED
REPUTATION.
 INGESTION OF DIURETICS
 ADULTERATE SPECIMEN USING BLEACH,
VINEGAR AND OTHERS THAT INTERFERE
INITIAL IMMUNOASSAY TESTS
 TESTS ARE ROUTINELY TESTED (pH,
CREATINE, SPECIFIC GRAVITY, COLOR
AND SMELL
HUMAN PERFORMANCE TESTING
 PRESENCE OF ETHANOL AND OTHER
DRUGS AND CHEMICALS IN BLOOD,
BREATH, OR OTHER SPECIMENS AND
EVALUATION OF THEIR ROLE IN
MODIFYING HUMAN PERFORMANCE
AND BEHAVIOR.
 DETERMINE IMPAIRMENT WHILE
DRIVING UNDER INFLUENCE OF
ETHANOL AND DRUGS
 STUDIES TEND TO REPORT HIGHEST
DRUG-USE ACCIDENT RATES ARE
ASSOCIATED WITH THE USE OF SUCH
ILLICIT OR CONTROLLED DRUGS AS
COCAINE, BENZODIAZEPINES,
MARIJUANA, AND PHENCYCLIDINE.
COURTROOM TESTIMONY
 FORENSIC TOXICOLOGIST OFTEN IS
CALLED UPON TO TESTIFY IN LEGAL
PROCEEDINGS AS AN “EXPERT
WITNESS”
 OBJECTIVE TESTIMONY- DESCRIPTION
OF ANALYTICAL METHODS AND
FINDINGS
 “OPINION”- OFFERED AS FORENSIC
TOXICOLOGIST TESTIFIES AS TO THE
INTERPRETATION OF ANALYTICAL
ROLE IN CLINICAL
TOXICOLOGY
 AS AN AID IN DIAGNOSIS AND
TREATMENT OF TOXIC INCIDENTS, AS
WELL IN MONITORING THE
EFFECTIVENESS OF TREATMENT
REGIMENS
 USEFUL TO IDENTIFY THE NATURE OF
TOXIC EXPOSURE AND MEASURE THE
AMOUNT OF TOXIC SUBSTANCE THAT
HAS BEEN ABSORBED.
 THIS MAY PERMIT A CLINICAL
JUDGMENT AS TO WETHER TREATMENT
IS VIGOROUS AND AGGRESSIVE OR
WETHER SIMPLE OBSERVATION AND
SYMPTOTIC TREATMENT OF THE
PATIENT IS SUFFICIENT.
ROLE IN THERAPEUTIC
MONITORING
 ADMINISTRATION OF DRUGS FOR
LONG TERM THERAPY WAS BASED
LARGELY ON EXPERIENCE
 DOSAGE AMOUNT WAS SELECTED AND
ADMINISTERED AT APPROPRIATE
INTERVALS BASED ON WHAT THE
CLINICIAN HAD LEARNED WAS
GENERALLY BY MOST PATIENTS.
 IF THE DRUG IS INEFFECTIVE DOSE
WILL INCREASED.
 IF TOXICITY IS DEVELOPED DOSE IS
DECREASED OR THE FREQUENCY OF
DOSING IS ALTERED.
 DIFFERENT DOSAGE FORM MIGHT BE
SUBSTITUTED
 ESTABLISHING DOSAGE REGIMEN IS
DIFFICULT IN CHILDREN AND ELDERLY.
 FACTORS RESPOSIBLE FOR VARIABILITY IN
RESPONSES TO DRUG THERAPY INCLUDES:
 RATE AND EXTEND OF DRUG ABSORPTION.
 DISTRIBUTION, AND BINDING IN TISSUES
AND FLUIDS,
 RATE OF METABAOLISM AND EXCRETION
 PATHOLOGIC CONDITIONS
 AND INTERACTION WITH OTHER DRUGS.
 MONI TORING OF PLASMA OR SERUM
CONCENTRATION A REGULAR
INTERVALS WILL DETECT DEVIATIONS
FROM THE AVERAGE SERUM
CONCENTRATION WHICH IN TURN, MAY
SUGGEST THAT ONE OR MORE OF
THESE VARIABLES NEED TO BE
IDENTIFIED AND CORRECTED.
THANK YOU!

A Analytical and forensic toxicology.pptx

  • 1.
  • 2.
  • 3.
     APPLICATION OFTOOLS OF ANALYTICAL CHEMISTRY TO THE QUALITATIVE AND QUANTITATIVE ESTIMATIO OF CHEMICALS THAT MAY EXERT ADVERSE EFFECTS ON LIVING ORGANISMS
  • 4.
  • 5.
     USE OFTOXICOLOGY FOR THE PURPOSES OF LAW  IDENTIFY ANY CHEMICAL THAT MAY SERVE AS A CAUSATIVE AGENT IN INFLICTING DEATH OR INJURY IN HUMANS OR IN CAUSATING DAMAGE TO PROPERTY
  • 6.
    TOXICOLOGICAL INVESTIGATION OF APOISON DEATH INVOLVES:  OBTAINING THE CASE HISTORY IN AS MUCH DETAIL AS POSSIBLE AND GATHERING SUITABLE SPECIMENS  CONDUCTING SUITABLE TOXICOLOGICAL ANALYSES BASED ON THE AVAILABLE SPECIMENS AND;  INTERPRETATION OF THE ANYLICAL FINDINGS
  • 7.
    SYSTEMATIC/STANDARD APPROACH (Chapuis-1873)  GASES-MEASURED BYGAS CHROMATOGRAPHY (GC)  VOLATILE SUBSTANCE- VAPORIZE AT AMBIANT TEMPERATURE GC IS SIMPLEST APPROACH FOR SEPARATION AND QUANTIFICATION  CORROSIVE AGENTS- MINERAL ACIDS AND BASES, CONSIST OF IONS THAT ARE TISSUE CONSTITUENTS, CHEMICAL TECNIQUES IS APPLIED
  • 8.
     ME TALS-ENCOUNTEREDFREQUENTLY AS OCCUPATIONAL AND ENVIRONMENTAL HAZARDS, SEPARATION INVOLVES DESCTRUCTION OF THE ORGANIC MATRIX BY CHEMICAL AND THERMAL OXIDATION.  ANIONS AND NONMETALS- ANALYTICAL CHALENGE SINCE RARELY ENCOUNTERED.  NONVOLATILE ORGANIC SUBSTANCES- LARGEST GROUP (PESTCIDES, NATURAL PRODUCTS, POLLUTANTS, AND INDUSTRIAL COMPOUNDS.
  • 9.
  • 10.
    ROLE IN GENERAL ANDFORENSIC TOXICOLOGY
  • 11.
     CHEMICAL UNDERSTUDY MUST BE PURE OR NATURE OF ANY CONTAMINANT WELL- CHARACTERIZED TO ENABLE INTERPRETATION OF THE EXPERIMENTAL RESULTS WITH VALIDITY.  CHEMICALS MAY DEGRADE WHEN IN CONTACT WITH AIR, BY EXPOSURE TO ULTRAVIOLET OR OTHER RADIATION, BY INTERACTION WITH CONSTITUENTS OF DOSING SOLUTINS AND OTHER MEANS.
  • 12.
     DEVELOPIN ANAYTICALPROCEDURE BY WHICH THESE CHANGES CAN BE RECOGNIZED AND CORRECTED IS ESSNTIAL IN ACHIEVING CONSISTENT AND RELIABLE RESULTS OVER THE COURSE OF STUDY.  ANALYTICAL METHODS ARE NECESSARY TO DETERMINE THE BIOAVAILABILITY OF COMPOUND THAT IS UNDER STUDY.
  • 13.
    ROLE IN FORENSIC TOXICOLOGY INCLUDES QUALITATIVE AND QUANTITAVE ANALYSIS OF DRUGS OR POISONS IN BIOLOGICAL SPECIMENS COLLECTED AT AUTOPSY AND ANALYTICAL FINDINGS WITH RESPECT TO THE PHYSIOLOGICAL AND BEHAVIORAL EFFECTS OF THE DETECTED CHEMICALS ON THE DECEASED AT THE TIME OR INJURY AND/OR DEATH.
  • 14.
     RESULTS OFPOSTMODERN TOXICOLOGICAL TESTING PROVIDE VALAUABLE EPIDEMIOLOGIC AND STATISTIC DATA.  CHEMICAL IDENTITY AND TOXICITY OF NOVEL ANALOGS OF PSYCHOACTIVE AGENTS THAT ARE SUBJECT TO ABUSE, INCLUDING “DESIGNER DRUGS” SUCH AS “CHINA WHITE” (METHYLFENTANYL), “ECSTASY” (METHYLDIOXYMETHAMPHETAMINE), AND GHB (GAMMA-HYDROXYBUTYRIC ACID).
  • 15.
    TOXICOLOGICAL INVESTIGATION OF APOISON DEATH three steps:  (1) obtaining the case history and suitable specimens,  (2) the toxicologic analyses, and  (3) the interpretation of the analytic  findings
  • 16.
    CASE HISTORY OFSPECIMENS  Today, thousands of compounds are readily available that are lethal if ingested, injected, or inhaled.  Usually, a limited amount of specimen is available on which to perform analyses; therefore it is imperative that, before the analyses are initiated, as much information as possible concerning the facts of the case be collected
  • 17.
    TOXICOLOGICAL ANALYSIS  Beforethe analysis begins, several factors must be considered, the amount of specimen available, the nature of the poison sought, and the possible biotransformation of the poison.  In cases involving oral administration of the poison, the gastrointestinal (GI) contents are analyzed first because large amounts of residual unabsorbed poison may be present.
  • 18.
  • 19.
     URINE ANALYSISFOR CONTROLLED OR ILLICIT DRUGS  ROUTINELY IN MILITARY SERVICES, REGULATED TRANSPORTATION AND NUCLEAR INDUSTRIES, MANY FEDERAL AND STATE AGENCIES, PUBLIC UTILITIES, FEDERAL AND STATE CRIMINAL JUSTICE SYSTEMS, AND NUMEROUS PRIVATE BUSINESS AND INDUSTRIES.
  • 20.
     SIGNIFICANT ANDETHICAL RAMIFICATIONS  POSITIVE RSULT- MAY NOT BE EMPLOYED, DISMISSED FROM JOB, BE COURT-MARTIALED, SUFFER DAMAGED REPUTATION.
  • 21.
     INGESTION OFDIURETICS  ADULTERATE SPECIMEN USING BLEACH, VINEGAR AND OTHERS THAT INTERFERE INITIAL IMMUNOASSAY TESTS  TESTS ARE ROUTINELY TESTED (pH, CREATINE, SPECIFIC GRAVITY, COLOR AND SMELL
  • 22.
  • 23.
     PRESENCE OFETHANOL AND OTHER DRUGS AND CHEMICALS IN BLOOD, BREATH, OR OTHER SPECIMENS AND EVALUATION OF THEIR ROLE IN MODIFYING HUMAN PERFORMANCE AND BEHAVIOR.  DETERMINE IMPAIRMENT WHILE DRIVING UNDER INFLUENCE OF ETHANOL AND DRUGS
  • 24.
     STUDIES TENDTO REPORT HIGHEST DRUG-USE ACCIDENT RATES ARE ASSOCIATED WITH THE USE OF SUCH ILLICIT OR CONTROLLED DRUGS AS COCAINE, BENZODIAZEPINES, MARIJUANA, AND PHENCYCLIDINE.
  • 25.
  • 26.
     FORENSIC TOXICOLOGISTOFTEN IS CALLED UPON TO TESTIFY IN LEGAL PROCEEDINGS AS AN “EXPERT WITNESS”  OBJECTIVE TESTIMONY- DESCRIPTION OF ANALYTICAL METHODS AND FINDINGS  “OPINION”- OFFERED AS FORENSIC TOXICOLOGIST TESTIFIES AS TO THE INTERPRETATION OF ANALYTICAL
  • 27.
  • 28.
     AS ANAID IN DIAGNOSIS AND TREATMENT OF TOXIC INCIDENTS, AS WELL IN MONITORING THE EFFECTIVENESS OF TREATMENT REGIMENS  USEFUL TO IDENTIFY THE NATURE OF TOXIC EXPOSURE AND MEASURE THE AMOUNT OF TOXIC SUBSTANCE THAT HAS BEEN ABSORBED.
  • 29.
     THIS MAYPERMIT A CLINICAL JUDGMENT AS TO WETHER TREATMENT IS VIGOROUS AND AGGRESSIVE OR WETHER SIMPLE OBSERVATION AND SYMPTOTIC TREATMENT OF THE PATIENT IS SUFFICIENT.
  • 30.
  • 31.
     ADMINISTRATION OFDRUGS FOR LONG TERM THERAPY WAS BASED LARGELY ON EXPERIENCE  DOSAGE AMOUNT WAS SELECTED AND ADMINISTERED AT APPROPRIATE INTERVALS BASED ON WHAT THE CLINICIAN HAD LEARNED WAS GENERALLY BY MOST PATIENTS.
  • 32.
     IF THEDRUG IS INEFFECTIVE DOSE WILL INCREASED.  IF TOXICITY IS DEVELOPED DOSE IS DECREASED OR THE FREQUENCY OF DOSING IS ALTERED.  DIFFERENT DOSAGE FORM MIGHT BE SUBSTITUTED  ESTABLISHING DOSAGE REGIMEN IS DIFFICULT IN CHILDREN AND ELDERLY.
  • 33.
     FACTORS RESPOSIBLEFOR VARIABILITY IN RESPONSES TO DRUG THERAPY INCLUDES:  RATE AND EXTEND OF DRUG ABSORPTION.  DISTRIBUTION, AND BINDING IN TISSUES AND FLUIDS,  RATE OF METABAOLISM AND EXCRETION  PATHOLOGIC CONDITIONS  AND INTERACTION WITH OTHER DRUGS.
  • 34.
     MONI TORINGOF PLASMA OR SERUM CONCENTRATION A REGULAR INTERVALS WILL DETECT DEVIATIONS FROM THE AVERAGE SERUM CONCENTRATION WHICH IN TURN, MAY SUGGEST THAT ONE OR MORE OF THESE VARIABLES NEED TO BE IDENTIFIED AND CORRECTED.
  • 35.